Bank of New York Mellon Corp - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$8,433,000
+43.4%
362,886
-1.7%
0.00%0.0%
Q1 2018$5,879,000
-21.4%
369,330
+2.6%
0.00%0.0%
Q4 2017$7,479,000
+48.2%
359,894
+2.2%
0.00%
+100.0%
Q3 2017$5,047,000
-16.3%
352,211
+1.0%
0.00%
-50.0%
Q2 2017$6,032,000
+34.2%
348,751
-14.4%
0.00%
+100.0%
Q1 2017$4,494,000
-22.3%
407,421
+2.2%
0.00%
-50.0%
Q4 2016$5,785,000
-42.3%
398,477
-2.4%
0.00%
-33.3%
Q3 2016$10,026,000
+41.4%
408,406
+16.0%
0.00%
+50.0%
Q2 2016$7,093,000
-27.2%
352,168
-4.9%
0.00%
-33.3%
Q1 2016$9,738,000
-74.4%
370,253
-0.9%
0.00%
-72.7%
Q4 2015$37,990,000
-20.9%
373,748
+3.6%
0.01%
-26.7%
Q3 2015$48,018,000
-39.7%
360,908
+0.6%
0.02%
-31.8%
Q2 2015$79,674,000
-3.4%
358,652
-13.6%
0.02%
+4.8%
Q1 2015$82,461,000
+35.5%
415,174
-2.4%
0.02%
+31.2%
Q4 2014$60,872,000
+6.3%
425,360
-2.5%
0.02%0.0%
Q3 2014$57,267,000
+16.8%
436,476
+17.3%
0.02%
+23.1%
Q1 2014$49,047,000
+10.3%
372,057
-1.7%
0.01%
+8.3%
Q4 2013$44,456,000
-42.9%
378,678
-49.3%
0.01%0.0%
Q3 2013$77,914,000
+155.9%
746,808
+111.2%
0.01%
+20.0%
Q2 2013$30,443,000
+1522050.0%
353,670
+1768250.0%
0.01%
Q1 2013$2,000200.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders